Exploration of Optimal Experimental Settings to Detect Human Papillomavirus From Menstrual Blood in Women With High-grade Squamous Intraepithelial Lesion or High-risk Human Papillomavirus Infection
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Female
Human Papillomavirus
Female
Human Papillomavirus
Trial Information
Exploration of Optimal Experimental Settings to Detect Human Papillomavirus From Menstrual Blood in Women With High-grade Squamous Intraepithelial Lesion or High-risk Human Papillomavirus Infection
Inclusion Criteria:
- Premenopausal women with HSIL at Pap test or high-risk HPV
Exclusion Criteria:
- Suspicious cancer
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
HPV detection rate in menstrual blood
Outcome Description:
The first menstrual period after enrollment is assumed to occur within 2 months. At that time, the participant used pads and send the used pads to investigators. The investigator do procedures to detect HPV in pads.
Outcome Time Frame:
First period after enrollment usually within 2 months after enrollment
Safety Issue:
No
Authority:
Republic of Korea: Korean Food and Drug Administration
Study ID:
SNUBH_GO_001
NCT ID:
NCT01506128
Start Date:
January 2012
Completion Date:
January 2013
Related Keywords:
- Human Papillomavirus
- HPV
- Menstrual blood
- HPV detection using menstrual blood
- Papillomavirus Infections
Name | Location |
|---|
